跳至主要内容
临床试验/NCT06456736
NCT06456736尚未招募不适用

Clinical Features and Prognostic Markers in Adult Patients With AE Requiring ICU Treatment

Central South University0 个研究点目标入组 200 人开始时间: 2024年6月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200
主要终点
Modified Rankin Scale

研究概览

简要总结

Autoimmune encephalitis (AE) is a potentially life-threatening inflammation of the central nervous system (CNS) and constitutes 20%-30% of encephalitis cases in adults AE often leads to subacute, severe, and debilitating encephalitis necessitating long-term management in a neurologic intensive care unit (ICU). This study aims to explore the predictive factors for poor clinical outcomes by analyzing the clinical characteristics and prognosis of adult patients with critical AE requiring ICU admission. Prospective observational single center study in neurologic ICU, the second Xiangya hospital, Central South University. All patients admitted to the ICU for probable or confirmed AE (2022 Chinese guidelines for diagnosis and treatment of AE) will be included. Factors associated with a poor prognosis will be identified by multivariate analysis using a logistic regression.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed as either ''definite'' or ''probable'' AE based on Chinese guidelines for diagnosis and treatment of AE (version 2022)
  • Age ≥ 15 years
  • Admission to an adult ICU during the course of the disease

排除标准

  • Missing data on primary outcome
  • ICU length of stay of 24 hours or less.

结局指标

主要结局

Modified Rankin Scale

时间窗: 12 months

The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It has become the most widely used clinic. mRS is scored on a scale of 0 to 6. The higher the score, the worse the prognosis

次要结局

  • Mortality(12 months)
  • Rate of complications(12 months)

研究者

发起方
Central South University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lixia Qin

Principal Investigator

Central South University

相似试验